Strive funds are available through online brokerage firms.
STXK
Strive Small-Cap ETF
Fund Objective
The Strive Small-Cap ETF (STXK) is a passively managed exchange traded fund (ETF) that seeks exposure to the smallest 600 corporations by market capitalization of the Bloomberg US 600 Total Return Index.
Fund Description
STXK offers exposure to small-capitalization U.S. corporations through a cost-efficient index product. Through Corporate Governance practices, including voting proxy shares and proactively engaging with management teams and boards, Strive aims to unlock value across all corporations in STXK's portfolio by mandating companies to focus on excellence.
- Fact Sheet
- Prospectus
- SAI
- Summary Prospectus
- Part F Q1
- Part F Q3
- Form 9837
- 2025 Dividend Schedule
- Form N-PX Proxy Voting Record
- Annual Financials
- Annual Schedule of Investments
- Annual Tailored Shareholder Report
- Semi-Annual Financials
- Semi-Annual Schedule of Investments
- Semi-Annual Tailored Shareholder Report
| Fund Data & Pricing | |
|---|---|
| Net Assets as of 11/24/2025 | $63.72m |
| NAV | $32.51 |
| Shares Outstanding | 1,960,000 |
| Premium/discount Percentage | 0.06% |
| Closing Price | $32.53 |
| Median 30 Day Spread | 0.12% |
Data as of 11/24/2025
Median 30 Day Spread is a calculation of Fund's median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, computed by: identifying the Fund's national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values.
The Fund expects to declare and to distribute its net investment income, if any, to shareholders as dividends quarterly. The amount of any distribution will vary, and there is no guarantee the Fund will pay either an income dividend or a capital gains distribution.
| Fund Information | |
|---|---|
| Inception Date | 11/09/2022 |
| Ticker | STXK |
| Primary Exchange | NYSE |
| CUSIP | 02072L573 |
| Expense Ratio | |
| 30 Day SEC Yield * | |
30 Day SEC Yield The yield is calculated with a standardized formula and represents net investment income earned by a fund over a 30-day period, expressed as an annual percentage rate based on the fund's share price. The yield includes the effect of any fee waivers and/or reimbursements. Without waivers, yields would be reduced. This is also referred to as the "standardized yield", “30-Day Yield” and “Current Yield”.
| Performance | Quarter end returns as of 09/30/2025 | |||
|---|---|---|---|---|
| Avg. Annualized | ||||
| Quarter | 1 Year | 3 Year | Since Inception | |
| NAV | 9.52% | 7.18% | 12.91% | |
| Market Price | 9.47% | 7.05% | 12.87% | |
| Benchmark | 9.68% | 7.52% | 13.15% | |
Expense ratio: 0.18%
Inception Date: 11/09/2022
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 855-427-7360. Short term performance, in particular, is not a good indication of the fund's future performance, and an investment should not be made based solely on returns.
Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.
NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.
| Distribution Detail | |||
|---|---|---|---|
| EX- Date | Record Date | Income | Payable Date |
| 09/29/2025 | 09/29/2025 | 0.09843319 | 09/30/2025 |
| 06/27/2025 | 06/27/2025 | 0.18670453 | 06/30/2025 |
| 3/28/2025 | 3/28/2025 | 0.00195192 | 3/31/2025 |
| 12/30/2024 | 12/30/2024 | 0.16200642 | 12/31/2024 |
| 9/27/2024 | 9/27/2024 | 0.17048813 | 9/30/2024 |
| 6/27/2024 | 6/27/2024 | 0.10235338 | 6/28/2024 |
| 3/26/2024 | 3/27/2024 | 0.07770948 | 3/28/2024 |
| 12/20/2023 | 12/21/2023 | 0.13560496 | 12/22/2023 |
| 9/27/2023 | 9/28/2023 | 0.07886566 | 9/29/2023 |
| 6/28/2023 | 6/29/2023 | 0.0563215 | 6/30/2023 |
| 3/29/2023 | 3/30/2023 | 0.05990216 | 3/31/2023 |
| 12/29/2022 | 12/30/2022 | 0.07522 | 1/6/2023 |
| TOP 10 HOLDINGS | |||||
|---|---|---|---|---|---|
| % Of Net Assets | Name | Ticker | CUSIP | Shares Held | Market Value |
| 0.69% | Guardant Health Inc | GH | 40131M109 | 3,937 | 437,991.25 |
| 0.46% | COEUR MINING INC. | CDE | 192108504 | 19,519 | 290,442.72 |
| 0.45% | Hecla Mining Co | HL | 422704106 | 19,623 | 283,748.58 |
| 0.42% | Columbia Banking System Inc | COLB | 197236102 | 9,715 | 267,551.10 |
| 0.41% | Cytokinetics Inc | CYTK | 23282W605 | 3,934 | 264,404.14 |
| 0.41% | Rigetti Computing Inc | RGTI | 76655K103 | 9,756 | 259,216.92 |
| 0.41% | Avidity Biosciences Inc | RNA | 05370A108 | 3,676 | 261,731.20 |
| 0.41% | Sanmina Corp | SANM | 801056102 | 1,702 | 261,614.42 |
| 0.40% | Advanced Energy Industries Inc | AEIS | 007973100 | 1,238 | 255,077.52 |
| 0.40% | American Healthcare REIT Inc | AHR | 398182303 | 5,227 | 255,077.60 |
Data as of 11/25/2025. Holdings are subject to change.
